Basal cell carcinomas, the most common form of skin cancer, occur in chronically sun-exposed areas such as the face. Locally ...

Talimogene laherparepvec (T-VEC) demonstrates efficacy in cutaneous BCC, enhancing resectability and altering immune cell ...

As our knowledge of science and the human body expands, so too do doctors have more tools at hand when treating cancer. One relatively recent development in this sphere is the use of oncolytic virus ...

But doctors now believe that what the drugs do is cure or relieve a viral-induced cancer, after the virus itself may have vanished. Thus they may give the body an opportunity to develop its own ...

This finding could potentially be used to develop the Semliki Forest virus as an agent for treating brain cancer. The study has been published in Nature Communications. Semliki Forest virus was ...

Cold Genesys is a clinical-stage company developing an oncolytic virus (CG0070) for multiple tumor types as a single agent and in combination with immune system checkpoint inhibitors. Already with ...

TVEC is a genetically modified herpes simplex virus that specifically destroys tumor cells and simultaneously activates the immune system. The aim of the study was to reduce the size of the tumor ...